HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

Benzinga Newsdesk www.benzinga.com Negative 74.6%

Neg 74.6% Neu 0% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the price target from $10 to $9.5.